P. Mandal

发表

Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.

A. Akram, G. Fleming, A. Hill, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.

D. Davidson, M. K. Sidhu, A. Hill, 2014, The Lancet. Respiratory medicine.

Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis

A. Akram, A. Hill, J. Chalmers, 2011, Intensive Care Medicine.

Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis

A. Akram, A. Hill, J. Chalmers, 2010, Thorax.

Bronchiectasis: an update on current pharmacotherapy and future perspectives

M. K. Sidhu, A. Hill, P. Mandal, 2014, Expert opinion on pharmacotherapy.

Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia.

A. Akram, A. Hill, J. Chalmers, 2010, Chest.

Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.

A. Akram, A. Hill, J. Chalmers, 2011, The Journal of antimicrobial chemotherapy.

Physician Judgment Is A Crucial Adjunct To Pneumonia Severity Scores In Low Risk Patients.

J. Chalmers, P. Mandal, A. Hill, 2011 .

Explorer Atorvastatin as a stable treatment in bronchiectasis : a randomised controlled trial

D. Davidson, M. K. Sidhu, A. Hill, 2017 .

Developing drug therapies in bronchiectasis

M. K. Sidhu, A. Hill, P. Mandal, 2015, Expert opinion on investigational drugs.

Vascular complications are associated with poor outcome in community-acquired pneumonia.

A. Akram, A. Hill, J. Chalmers, 2011, QJM : monthly journal of the Association of Physicians.

S16 A Randomised Controlled Trial Of Atorvastatin As A Stable Treatment In Bronchiectasis

D. Davidson, A. Hill, J. Chalmers, 2014, Thorax.

Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis.

A. Hill, J. Chalmers, J. Scott, 2013, QJM : monthly journal of the Association of Physicians.

Safety and efficacy of CURB 65-guided antibiotic therapy in community-acquired pneumonia

A. Akram, A. Hill, J. Chalmers, 2011 .

Contact tracing in pulmonary and non-pulmonary tuberculosis.

A. Hill, J. Chalmers, I. Laurenson, 2012, QJM : monthly journal of the Association of Physicians.

A proof of concept randomized control trial of atorvastatin as a stable therapy in bronchiectasis

P. Mandal, 2014 .

Statins in community acquired pneumonia: Evidence from experimental and clinical studies.

A. Akram, A. Hill, J. Chalmers, 2010, Respiratory medicine.

Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients

A. Akram, A. Hill, J. Chalmers, 2011, European Respiratory Journal.

A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.

A. Hill, W. Pollock, P. Mandal, 2012, Respiratory medicine.

Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care.

A. Akram, A. Hill, J. Chalmers, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.

A. Akram, A. Hill, J. Chalmers, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis

A. Akram, A. Hill, J. Chalmers, 2022 .

Bronchiectasis: breaking the cycle of inflammation and infection.

A. Hill, P. Mandal, 2013, The Lancet. Respiratory medicine.

Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis.

A. Morice, A. Hill, J. Chalmers, 2013, Respiratory medicine.

Sui Generis Development of Molecular Markers from Transcriptome of Crotalaria juncea, a Fabaceae Family Bast Fiber Crop

D. Saha, A. K. Shaw, S. Datta, 2022, Journal of Natural Fibers.

Pulmonary malakoplakia: a rare presentation mimicking extensive stage IV lung cancer

W. Wallace, K. Skwarski, P. Mandal, 2011, European Respiratory Journal.